The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen

Human estrogen receptors α and β (ERα and ERβ) greatly differ in their target genes, transcriptional potency and cofactor-binding capacity, and are differentially expressed in various tissues. In classical estrogen response element (ERE)-mediated transactivation, ERβ has a markedly reduced activation potential compared with ERα; the mechanism underlying this difference is unclear. Here, we report that the binding of steroid receptor coactivator-1 (SRC-1) to the AF-1 domain of ERα is essential but not sufficient to facilitate synergy between the AF-1 and AF-2 domains, which is required for a full agonistic response to estradiol (E2). Complete synergy is achieved through the distinct hinge domain of ERα, which enables combined action of the AF-1 and AF-2 domains. AF-1 of ERβ lacks the capacity to interact with SRC-1, which prevents hinge-mediated synergy between AF-1 and AF-2, thereby explaining the reduced E2-mediated transactivation of ERβ. Transactivation of ERβ by E2 requires only the AF-2 domain. A weak agonistic response to tamoxifen occurs for ERα, but not for ERβ, and depends on AF-1 and the hinge-region domain of ERα.

[1]  W. Zwart,et al.  Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1. , 2009, Molecular endocrinology.

[2]  J. Ingle,et al.  Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain. , 2008, Molecular endocrinology.

[3]  Xiaodong Cheng,et al.  Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. , 2008, Molecular cell.

[4]  Barry Komm,et al.  Estrogen Receptors (cid:1) and (cid:2) as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding , 2008 .

[5]  J. Gustafsson,et al.  A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells , 2008, Oncogene.

[6]  N. Picard,et al.  Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta. , 2008, Molecular endocrinology.

[7]  W. Zwart,et al.  PKA‐induced resistance to tamoxifen is associated with an altered orientation of ERα towards co‐activator SRC‐1 , 2007, The EMBO journal.

[8]  W. Zwart,et al.  Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor α , 2007, Molecular Cancer Therapeutics.

[9]  M. MacCoss,et al.  Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase , 2007, Proceedings of the National Academy of Sciences.

[10]  J. Gustafsson,et al.  Role of estrogen receptor β in uterine stroma and epithelium: Insights from estrogen receptor β−/− mice , 2006, Proceedings of the National Academy of Sciences.

[11]  Adam T. Szafran,et al.  Estrogen-receptor-α exchange and chromatin dynamics are ligand- and domain-dependent , 2006, Journal of Cell Science.

[12]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[13]  M. Y. Kim,et al.  Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. , 2006, Molecular endocrinology.

[14]  J. Gustafsson,et al.  Role of estrogen receptor β in colonic epithelium , 2006 .

[15]  C. J. Barnes,et al.  P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. , 2006, Cancer research.

[16]  J. Gustafsson,et al.  Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 , 2005, Oncogene.

[17]  J. Gustafsson,et al.  A previously uncharacterized role for estrogen receptor beta: defeminization of male brain and behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Klinge,et al.  Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors , 2004 .

[19]  J. Gustafsson,et al.  Characterization of the ERbeta-/-mouse heart. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Muyan,et al.  Single-Chain Estrogen Receptors (ERs) Reveal that the ERα/β Heterodimer Emulates Functions of the ERα Dimer in Genomic Estrogen Signaling Pathways , 2004, Molecular and Cellular Biology.

[21]  Fabio Stossi,et al.  Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. , 2004, Endocrinology.

[22]  F. Gannon,et al.  The Relative Contribution Exerted by AF-1 and AF-2 Transactivation Functions in Estrogen Receptor α Transcriptional Activity Depends upon the Differentiation Stage of the Cell* , 2004, Journal of Biological Chemistry.

[23]  A. Floore,et al.  Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer. , 2004, Cancer cell.

[24]  E. V. van Munster,et al.  Probing plasma membrane microdomains in cowpea protoplasts using lipidated GFP‐fusion proteins and multimode FRET microscopy , 2004, Journal of microscopy.

[25]  V. Jordan,et al.  The biological role of estrogen receptors α and β in cancer , 2004 .

[26]  V. Speirs,et al.  Oestrogen receptor β: what it means for patients with breast cancer , 2004 .

[27]  J. Hartman,et al.  Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .

[28]  Jianming Xu,et al.  Review of the in vivo functions of the p160 steroid receptor coactivator family. , 2003, Molecular endocrinology.

[29]  I. Talianidis,et al.  Dynamics of enhancer-promoter communication during differentiation-induced gene activation. , 2002, Molecular cell.

[30]  F. Lallemand,et al.  Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells , 2002, Oncogene.

[31]  M. Muyan,et al.  Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses. , 2002, Molecular endocrinology.

[32]  Russell Hilf,et al.  The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ERα and ERβ , 2002 .

[33]  R. Métivier,et al.  Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. , 2001, Molecular endocrinology.

[34]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[35]  T. Scanlan,et al.  Differential SERM activation of the estrogen receptors (ERα and ERβ) at AP-1 sites , 2001 .

[36]  C. Klinge,et al.  Resveratrol Acts as a Mixed Agonist / Antagonist for Estrogen Receptors a and b * , 2000 .

[37]  B. Katzenellenbogen,et al.  Conformational Changes and Coactivator Recruitment by Novel Ligands for Estrogen Receptor-α and Estrogen Receptor-β: Correlations with Biological Character and Distinct Differences among SRC Coactivator Family Members. , 2000, Endocrinology.

[38]  R. Tsien,et al.  Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Gustafsson.  An update on estrogen receptors. , 2000, Seminars in perinatology.

[40]  Scott T. Kelley,et al.  Phylogenetic Analyses Reveal Ancient Duplication of Estrogen Receptor Isoforms , 1999, Journal of Molecular Evolution.

[41]  J. Mester,et al.  Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Pols,et al.  Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. , 1999, Biochemical and biophysical research communications.

[43]  V. Giguère,et al.  Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. , 1999, Molecular cell.

[44]  H Grøn,et al.  Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Bastiaens,et al.  Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. , 1999, Trends in cell biology.

[46]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[47]  B. Katzenellenbogen,et al.  Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.). , 1998, Endocrinology.

[48]  B. Katzenellenbogen,et al.  Estrogen receptor activation function 1 works by binding p160 coactivator proteins. , 1998, Molecular endocrinology.

[49]  J. Gustafsson,et al.  Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.

[50]  J. Trowsdale,et al.  HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.

[51]  David M. Heery,et al.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.

[52]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[53]  B. O’Malley,et al.  Specific binding of estrogen receptor to the estrogen response element , 1989, Molecular and cellular biology.

[54]  F. Schaufele,et al.  Ligand-selective interdomain conformations of estrogen receptor-alpha. , 2007, Molecular endocrinology.

[55]  M. MacCoss,et al.  Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[56]  F. Schaufele,et al.  Ligand-selective interdomain conformations of estrogen receptor-α , 2007 .

[57]  Adam T. Szafran,et al.  Estrogen-receptor-alpha exchange and chromatin dynamics are ligand- and domain-dependent. , 2006, Journal of cell science.

[58]  J. Gustafsson,et al.  Role of estrogen receptor beta in colonic epithelium. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Gustafsson,et al.  Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Muyan,et al.  Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways. , 2004, Molecular and cellular biology.

[61]  J. Hartman,et al.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  V. Speirs,et al.  Oestrogen receptor beta: what it means for patients with breast cancer. , 2004, The Lancet. Oncology.

[63]  C. Klinge,et al.  Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. , 2004, Journal of molecular endocrinology.

[64]  V. Jordan,et al.  The biological role of estrogen receptors alpha and beta in cancer. , 2004, Critical reviews in oncology/hematology.

[65]  M. Muyan,et al.  The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. , 2002, Molecular endocrinology.

[66]  T. Scanlan,et al.  Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites. , 2001, Chemistry & biology.

[67]  B. Katzenellenbogen,et al.  Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. , 2000, Endocrinology.

[68]  C. Klinge,et al.  Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. , 2000, Endocrinology.

[69]  H. Pols,et al.  Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. , 1999, Biochemical and biophysical research communications.

[70]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[71]  Th. Förster.  Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .